Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Decision Making: P-value Method01:09

Decision Making: P-value Method

The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim  is also stated. These statements can act as null and alternative hypotheses:  a null hypothesis would be a neutral statement while the alternative hypothesis can have a...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Orchestrator multi-agent clinical decision support system for secondary headache diagnosis in primary care.

Journal of the American Medical Informatics Association : JAMIA·2026
Same author

Dual-transcriptomic analysis of human nasal transcriptome and microbiome reveals host-bacteria associations in symptomatic respiratory infection.

BMC genomics·2026
Same author

The Effect of Enforcing Fairness on Reshaping Explanations in Machine Learning Models.

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science·2026
Same author

A multimodal generative model for structured and unstructured electronic health records.

npj health systems·2026
Same author

Predicting the timing of first sustained cognitive worsening in Alzheimer's disease using real-world clinical data and machine learning.

medRxiv : the preprint server for health sciences·2026
Same author

The use of logic for machine learning models in sepsis.

Intensive care medicine experimental·2026
Same journal

HIV Transmission Dynamics in Greater Mexico City are Shaped by Dense Spatial Mixing.

Research square·2026
Same journal

A UCP1-IRES-Cre Knock-In Mouse Enables Specific Brown Adipocyte Targeting Without CNS Off-Target Expression.

Research square·2026
Same journal

Precision RNAi for Fibrodysplasia Ossificans Progressiva: a combinatorial, unimolecular, allele selective approach.

Research square·2026
Same journal

Perceptions of end-of-life care quality among bereaved closest contacts of community-dwelling older Australians: a cross-sectional survey of the ASPREE cohort.

Research square·2026
Same journal

Heavy-chain immune repertoire sequencing enables language-model prediction of antigen-specific antibodies.

Research square·2026
Same journal

25+ Years of TRPV4: From Discovery to Translational Horizons.

Research square·2026
See all related articles

Related Experiment Videos

A Decision-Theoretic Perspective on Fairness in Clinical Predictive Models.

Joshua W Anderson1, Nader Shaikh2, Gregory F Cooper3

  • 1Intelligent Systems Program, University of Pittsburgh, PA, USA.

Research Square
|May 18, 2026
PubMed
Summary
This summary is machine-generated.

Fairness in clinical prediction models is crucial. A revised model improved prediction fairness but not patient outcome fairness, highlighting the need to evaluate both aspects.

Related Experiment Videos

Area of Science:

  • Medical Informatics
  • Biostatistics
  • Health Equity

Background:

  • Fairness in statistical models, particularly clinical prediction models, is a significant concern.
  • Current fairness methods often prioritize parity in model predictions across groups, potentially overlooking broader clinical implications.
  • Patient outcomes are critical when assessing fairness in healthcare applications.

Purpose of the Study:

  • To evaluate the fairness of a revised clinical prediction model (UTICalc) using both prediction-based and outcome-based metrics.
  • To investigate the potential divergence between prediction-based and outcome-based fairness in clinical decision-making.
  • To propose a decision-theoretic framework for assessing fairness based on patient outcomes.

Main Methods:

  • Analysis of the UTICalc model, revised for improved racial fairness and tested on equal opportunity (true positive rate).
  • Development of a decision-theoretic framework incorporating patient outcome utilities and model predictions.
  • Construction of a decision tree to model the clinical decision process for urinary tract infection (UTI) in children.

Main Results:

  • The revised UTICalc model demonstrated improved performance on a prediction-based fairness metric (equal opportunity).
  • However, the model did not show improvement in an outcome-based fairness metric (expected utility parity).
  • This indicates a potential divergence between prediction-based and outcome-based fairness.

Conclusions:

  • Fairness evaluation in clinical prediction models should encompass both prediction performance and patient outcomes.
  • Relying solely on prediction-based fairness metrics may not adequately address fairness concerns in clinical practice.
  • A comprehensive approach integrating patient utilities is essential for robust fairness assessment in healthcare AI.